Ceragenix Appoints Former President of Boston Scientific-Europe and Former President of Baxter Healthcare-Asia to Board of Directors
June 16, 2005 08:30 ET
|
Ceragenix Pharmaceuticals
DENVER, June 16, 2005 (PRIMEZONE) -- OnSource Corporation (OTCBB:OSCE) d/b/a Ceragenix Pharmaceuticals ("Ceragenix" or the "Company"), has appointed four independent directors -- adding significant...
Ceragenix Appoints Russell Allen Vice President of Corporate Development
June 15, 2005 08:30 ET
|
Ceragenix Pharmaceuticals
DENVER, June 15, 2005 (PRIMEZONE) -- OnSource Corporation (OTCBB:OSCE) d/b/a Ceragenix Pharmaceuticals ("Ceragenix" or the "Company"), has named Russell L. Allen its new Vice President of Corporate...
Ceragenix Pharmaceuticals to File 510k for Reformulation of Epiceram
May 23, 2005 16:15 ET
|
Ceragenix Pharmaceuticals
DENVER, May 23, 2005 (PRIMEZONE) -- OnSource Corporation (OTCBB:OSCE), d/b/a Ceragenix Pharmaceuticals ("Ceragenix" or the "Company"), has withdrawn its pending Request for Designation from the...
Osmotics Pharma, Inc. and OnSource Corporation Complete Merger
May 11, 2005 08:30 ET
|
Ceragenix Pharmaceuticals
DENVER, May 11, 2005 (PRIMEZONE) -- OnSource Corporation ("OnSource") (OTCBB:OSCE) has completed its planned merger with Osmotics Pharma, Inc. ("OPI"), a specialty pharmaceutical company focused on...